Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:38 PM
Ignite Modification Date:
2025-12-24 @ 2:38 PM
NCT ID:
NCT04952259
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years old, no gender limit;
* Anterior wall STEMI within 12 hours of onset (diagnostic criteria: ischemic chest pain lasting ≥30min; ST-segment elevation or new left bundle branch block in two or more adjacent leads on the ECG; with or without Elevated myocardial markers), emergency PCI treatment is planned;
* Infarct-related coronary vascular anatomy is suitable for PCI treatment;
* Agree and cooperate to participate in this research, and sign an informed consent form
Exclusion Criteria:
* Past history of myocardial infarction history;
* The arteries related to infarction have received PCI in the past;
* Past CABG history;
* Killip grade of cardiac function ≥ grade III or cardiogenic shock;
* Systolic blood pressure ≤90mmHg;
* Bradycardia, heart rate \<60 beats/min, or atrioventricular block of degree II or more;
* Allergic to Shexiang Tongxin Dropping Pills
* Past history of asthma or severe COPD;
* Severe liver and kidney dysfunction;
* Participate in other clinical trials within 3 months;
* Pregnancy or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04952259
Study Brief:
Protocol Section:
NCT04952259